I am posting this for any of the doubters out ther

I am posting this for any of the doubters out there trying to break down or speculate on the last PR stating 2-3 weeks. If there was no PR at all I would Feel very safe with my investment in CYDY based on all the data collected from EIND’s, the countless DR testimonials that’s have actually used leronlimab on covid patients as opposed to maybe some hit piece on stat news you may have read online, I also believe in the MOA discussed early on by Bruce Patterson. In addition to all of that we had 2 DSMC looks in which if trial wasn’t looking safe or effective could have stopped or made negative changes such as add more patients change endpoint to maybe something easier or more attainable but not as important as mortality, no changes made only a suggestion to look at 75% at day 42 instead of waiting till day 28 of full trial that was taking a long time at the time. No changes very bullish sign. So with all that if there was complete silence after unblinding I would think that something great behind the scenes was happening. Now add into it that in last proactive video CEO states FDA MHRA want the unblinded raw data right away they said don’t want to wait for top line report.
Now let’s get into the last PR 2-3 weeks “Confidential discussions with US FDA, Health Canada, and MHRA. “Eager to release the results of discussions and data when the confidential discussions concluded” i will also add Remsadeath was approved for lowering hospital stay by 2 days and has some pretty nasty side effects. #Iamallin #cydy